JP2023071952A5 - - Google Patents

Info

Publication number
JP2023071952A5
JP2023071952A5 JP2023035901A JP2023035901A JP2023071952A5 JP 2023071952 A5 JP2023071952 A5 JP 2023071952A5 JP 2023035901 A JP2023035901 A JP 2023035901A JP 2023035901 A JP2023035901 A JP 2023035901A JP 2023071952 A5 JP2023071952 A5 JP 2023071952A5
Authority
JP
Japan
Prior art keywords
chelating agent
composition
inhalable composition
dose
inhalable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023035901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023071952A (ja
JP7848150B2 (ja
Filing date
Publication date
Priority claimed from PCT/AU2018/050609 external-priority patent/WO2018232452A1/en
Application filed filed Critical
Publication of JP2023071952A publication Critical patent/JP2023071952A/ja
Publication of JP2023071952A5 publication Critical patent/JP2023071952A5/ja
Application granted granted Critical
Publication of JP7848150B2 publication Critical patent/JP7848150B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023035901A 2017-06-20 2023-03-08 肺炎症を低減させる方法 Active JP7848150B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2017902365 2017-06-20
AU2017902365A AU2017902365A0 (en) 2017-06-20 Method For Reducing Lung Inflammation
PCT/AU2018/050609 WO2018232452A1 (en) 2017-06-20 2018-06-20 METHOD FOR REDUCING PULMONARY INFLAMMATION
JP2019571349A JP7729713B2 (ja) 2017-06-20 2018-06-20 肺炎症を低減させる方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019571349A Division JP7729713B2 (ja) 2017-06-20 2018-06-20 肺炎症を低減させる方法

Publications (3)

Publication Number Publication Date
JP2023071952A JP2023071952A (ja) 2023-05-23
JP2023071952A5 true JP2023071952A5 (https=) 2025-11-13
JP7848150B2 JP7848150B2 (ja) 2026-04-20

Family

ID=64735378

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019571349A Active JP7729713B2 (ja) 2017-06-20 2018-06-20 肺炎症を低減させる方法
JP2023035901A Active JP7848150B2 (ja) 2017-06-20 2023-03-08 肺炎症を低減させる方法
JP2025031885A Withdrawn JP2025098035A (ja) 2017-06-20 2025-02-28 肺炎症を低減させる方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019571349A Active JP7729713B2 (ja) 2017-06-20 2018-06-20 肺炎症を低減させる方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025031885A Withdrawn JP2025098035A (ja) 2017-06-20 2025-02-28 肺炎症を低減させる方法

Country Status (8)

Country Link
US (2) US11491126B2 (https=)
EP (1) EP3641749A4 (https=)
JP (3) JP7729713B2 (https=)
CN (1) CN111050762A (https=)
AU (2) AU2018286649B2 (https=)
BR (1) BR112019027257A2 (https=)
CA (1) CA3067857A1 (https=)
WO (1) WO2018232452A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI818601B (zh) * 2021-10-29 2023-10-11 原創生醫股份有限公司 用於上呼吸道給藥之組成物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
AU2016228976B2 (en) * 2015-03-11 2018-11-08 University Of Cincinnati Compositions and methods for treating bacterial infection
EP3383415B1 (en) * 2015-12-01 2021-03-31 Cornell University Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease

Similar Documents

Publication Publication Date Title
JP2024001036A5 (https=)
Levy et al. High-flow oxygen therapy and other inhaled therapies in intensive care units
RU2010150839A (ru) Внутрилегочное введения флуорохинолона
JP2011520911A5 (https=)
HRP20210704T1 (hr) Formulacija suhog praška koja sadrži antikolinergik, kortikosteroid i beta-adrenergik za davanje inhalacijom
NZ585856A (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
RU2019100425A (ru) Новая доза и препаративная форма
CA2421974A1 (en) Pulmonary delivery in treating disorders of the central nervous system
JP2015519404A5 (https=)
JP2020532531A5 (https=)
CO6260019A2 (es) Metodos para el tratamiento de desordenes gastrointestinales independientes de la ingesta de alimento
CN102325532A (zh) 用于减轻肺部炎症的左氧氟沙星吸入剂
JP2023071952A5 (https=)
US20090169487A1 (en) Essential Oil Diffusion
CN116096446A (zh) 脉冲递送气态药物的方法
WO2015014209A1 (zh) 稳定渗透压的丙酮酸药物组成及其在健康人和肺病病人中的排毒作用
AU2005316687B2 (en) Compositions and methods for pulmonary conditions
Hijiya et al. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia
Parameswara Anesthetic Concerns in Patients with Hyper‑reactive Airways
JP2020524172A5 (https=)
CN102552241A (zh) 芒柄花素在制备防治呼吸道炎症、哮喘药物中的应用
Poulakou et al. Inhaled antimicrobials for ventilator-associated pneumonia: practical aspects
JP2021535163A5 (https=)
CN108472375A (zh) 中重度流感的治疗方法
CN1230199C (zh) 氧化氮用于气道狭窄治疗的用途